Institution · Microbiotix (United States)
Most cited papers from Microbiotix (United States)
What are the most cited papers from Microbiotix (United States)?
The most cited paper from Microbiotix (United States) is "Characterization of the Surface Enhanced Raman Scattering (SERS) of Bacteria" (W. Ranjith Premasiri, Donald T. Moir, Mark S. Klempner et al., 2004), with 490 citations. Next come "In Vitro and In Vivo Evaluation of PEDOT Microelectrodes for Neural Stimulation and Recording" (323) and "Poly(3,4-ethylenedioxythiophene) (PEDOT) polymer coatings facilitate smaller neural recording electrodes" (290).
Showing 50 of 60 papers. Every paper with more than 30 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Characterization of the Surface Enhanced Raman Scattering (SERS) of Bacteria W. Ranjith Premasiri, Donald T. Moir, Mark S. Klempner et al. · The Journal of Physical Chemistry B | 16 Dec 2004 | 490 |
| 2 | In Vitro and In Vivo Evaluation of PEDOT Microelectrodes for Neural Stimulation and Recording Subramaniam Venkatraman, Jeffrey L. Hendricks, Zachary A. King et al. · IEEE Transactions on Neural Systems and Rehabilitation Engineering | 31 Jan 2011 | 323 |
| 3 | Poly(3,4-ethylenedioxythiophene) (PEDOT) polymer coatings facilitate smaller neural recording electrodes Kip A. Ludwig, Nicholas B. Langhals, Mike D Joseph et al. · Journal of Neural Engineering | 19 Jan 2011 | 290 |
| 4 | Recent advances toward a molecular mechanism of efflux pump inhibition Timothy J. Opperman, Son T. Nguyen · Frontiers in Microbiology | 5 May 2015 | 266 |
| 5 | Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives Hanno Sjuts, Attilio Vittorio Vargiu, Steven M. Kwasny et al. · Proceedings of the National Academy of Sciences | 14 Mar 2016 | 212 |
| 6 | Barcoding bacterial cells: a SERS‐based methodology for pathogen identification Ishwar Patel, W. Ranjith Premasiri, Donald T. Moir et al. · Journal of Raman Spectroscopy | 17 Oct 2008 | 206 |
| 7 | Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli Timothy J. Opperman, Steven M. Kwasny, Hong‐Suk Kim et al. · Antimicrobial Agents and Chemotherapy | 18 Nov 2013 | 201 |
| 8 | Respiratory Syncytial Virus–Induced Chemokine Production: Linking Viral Replication to Chemokine Production In Vitro and In Vivo Allison L. Miller, Terry L. Bowlin, Nicholas W. Lukacs · The Journal of Infectious Diseases | 9 Apr 2004 | 178 |
| 9 | Molecular Mechanism of MBX2319 Inhibition of Escherichia coli AcrB Multidrug Efflux Pump and Comparison with Other Inhibitors Attilio Vittorio Vargiu, Paolo Ruggerone, Timothy J. Opperman et al. · Antimicrobial Agents and Chemotherapy | 12 Aug 2014 | 176 |
| 10 | Static Biofilm Cultures of Gram‐Positive Pathogens Grown in a Microtiter Format Used for Anti‐Biofilm Drug Discovery Steven M. Kwasny, Timothy J. Opperman · Current Protocols in Pharmacology | Sep 2010 | 167 |
| 11 | Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections Alan R. Hauser, Joan C. Mecsas, Donald T. Moir · Clinical Infectious Diseases | 29 Mar 2016 | 152 |
| 12 | The use of a dual PEDOT and RGD-functionalized alginate hydrogel coating to provide sustained drug delivery and improved cochlear implant function Jennifer A. Chikar, Jeffrey L. Hendricks, Sarah M. Richardson-Burns et al. · Biomaterials | 17 Dec 2011 | 133 |
| 13 | Lack of AcrB Efflux Function Confers Loss of Virulence on Salmonella enterica Serovar Typhimurium Xuan Wang‐Kan, Jessica M. A. Blair, Barbara Chirullo et al. · mBio | 18 Jul 2017 | 130 |
| 14 | Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion Daniel Andrew Aiello, John David Williams, Helena Majgier-Báranowska et al. · Antimicrobial Agents and Chemotherapy | 23 Feb 2010 | 128 |
| 15 | Aqueous Processing and Fiber Spinning of Recombinant Spider Silks Steven M. Arcidiacono, Charlene M. Mello, Michelle M. Butler et al. · Macromolecules | 11 Jan 2002 | 112 |
| 16 | Identification of a Small-Molecule Entry Inhibitor for Filoviruses Arnab Basu, Bing Li, Debra M. Mills et al. · Journal of Virology | 27 Jan 2011 | 111 |
| 17 | Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study Amy Elizabeth Langdon, Drew J. Schwartz, Christopher Bulow et al. · Genome Medicine | 16 Feb 2021 | 92 |
| 18 | Solute Restriction Reveals an Essential Role for clag3-Associated Channels in Malaria Parasite Nutrient Acquisition Ajay D. Pillai, Wang Nguitragool, Brian Lyko et al. · Molecular Pharmacology | 5 Sep 2012 | 89 |
| 19 | New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion Arnab Basu, Aleksandar Antanasijevic, Minxiu Wang et al. · Journal of Virology | 7 Nov 2013 | 86 |
| 20 | Survey of Solvents for the Conrad–Limpach Synthesis of 4-Hydroxyquinolones Jean‐Cristophe Brouet, Shen Gu, Norton P. Peet et al. · Synthetic Communications | 2 Apr 2009 | 83 |
| 21 | Structure–activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors Son T. Nguyen, Steven M. Kwasny, Xiaoyuan Ding et al. · Bioorganic & Medicinal Chemistry | 12 Mar 2015 | 82 |
| 22 | Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays P WYDE, Edina H Moylett, Srikrishna N. Chetty et al. · Antiviral Research | 13 Apr 2004 | 75 |
| 23 | Coumarin-Based Inhibitors of Bacillus anthracis and Staphylococcus aureus Replicative DNA Helicase: Chemical Optimization, Biological Evaluation, and Antibacterial Activities Bing Jhang Li, Ramdas P. Pai, Di Ming et al. · Journal of Medicinal Chemistry | 26 Nov 2012 | 67 |
| 24 | Mutations in the Pseudomonas aeruginosa Needle Protein Gene pscF Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System Nicholas O. Bowlin, John David Williams, Claire A. Knoten et al. · Antimicrobial Agents and Chemotherapy | 28 Jan 2014 | 66 |
| 25 | Antibacterial Activity and Mechanism of Action of a Novel Anilinouracil-Fluoroquinolone Hybrid Compound Michelle M. Butler, William A. LaMarr, Kimberly A. Foster et al. · Antimicrobial Agents and Chemotherapy | 20 Dec 2006 | 65 |
| 26 | Advances in the Development of Therapeutics for Cytomegalovirus Infections Edward P. Acosta, Terry L. Bowlin, Jennifer Brooks et al. · The Journal of Infectious Diseases | 28 Sep 2019 | 64 |
| 27 | Hybrid Antibacterials. DNA Polymerase−Topoisomerase Inhibitors Chengxin Zhi et al. · Journal of Medicinal Chemistry | 25 Jan 2006 | 64 |
| 28 | Novel Small Molecule Entry Inhibitors of Ebola Virus Arnab Basu, Debra M. Mills, Daniel A. J. Mitchell et al. · The Journal of Infectious Diseases | 22 Jul 2015 | 62 |
| 29 | Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm Formation Timothy J. Opperman, Steven M. Kwasny, John David Williams et al. · Antimicrobial Agents and Chemotherapy | 4 Aug 2009 | 61 |
| 30 | The hydrophobic trap—the Achilles heel of RND efflux pumps Zachary D. Aron, Timothy J. Opperman · Research in Microbiology | 13 Nov 2017 | 57 |
| 31 | Synthesis of Substituted 6-Anilinouracils and Their Inhibition of DNA Polymerase IIIC and Gram-Positive Bacterial Growth Chengxin Zhi, Zheng‐Yu Long, Joseph J. Gambino et al. · Journal of Medicinal Chemistry | 15 May 2003 | 57 |
| 32 | Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection Bryan J. Berube, Katherine R. Murphy, Matthew C. Torhan et al. · Antimicrobial Agents and Chemotherapy | 15 Aug 2017 | 55 |
| 33 | Optimization of a novel series of pyranopyridine RND efflux pump inhibitors Zachary D. Aron, Timothy J. Opperman · Current Opinion in Microbiology | 24 May 2016 | 54 |
| 34 | Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models Gregory T. Robertson, Michael S. Scherman, David F. Bruhn et al. · Journal of Antimicrobial Chemotherapy | 29 Nov 2016 | 51 |
| 35 | Cytomegalovirus UL97 Mutations Affecting Cyclopropavir and Ganciclovir Susceptibility Sunwen Chou, Terry L. Bowlin · Antimicrobial Agents and Chemotherapy | 2 Nov 2010 | 51 |
| 36 | Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report Charles S. Dela Cruz et al. · Annals of the American Thoracic Society | Jul 2021 | 50 |
| 37 | trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo Zachary D. Aron, Atousa Mehrani, Eric D. Hoffer et al. · Nature Communications | 19 Mar 2021 | 50 |
| 38 | Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains Rekha G. Panchal, Ricky L. Ulrich, Douglas J. Lane et al. · Antimicrobial Agents and Chemotherapy | 28 Jul 2009 | 50 |
| 39 | Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication Bing Li, Norton P. Peet, Michelle M. Butler et al. · Molecules | 30 Dec 2010 | 50 |
| 40 | Cytomegalovirus UL97 Kinase Catalytic Domain Mutations That Confer Multidrug Resistance Sunwen Chou, Ronald J. Ercolani, Gail I. Marousek et al. · Antimicrobial Agents and Chemotherapy | 7 May 2013 | 48 |
| 41 | Synthesis and Antiviral Activities of Methylenecyclopropane Analogs with 6-Alkoxy and 6-Alkylthio Substitutions That Exhibit Broad-Spectrum Antiviral Activity against Human Herpesviruses Mark N. Prichard, John David Williams, Gloria Komazin-Meredith et al. · Antimicrobial Agents and Chemotherapy | 14 May 2013 | 46 |
| 42 | Pseudomonas aeruginosa: So many virulence factors, so little time* Alan R. Hauser · Critical Care Medicine | Sep 2011 | 44 |
| 43 | Synthesis and Antibacterial Activity of 3-Substituted-6-(3-ethyl-4-methylanilino)uracils Chengxin Zhi, Zheng‐Yu Long, Andrzej Manikowski et al. · Journal of Medicinal Chemistry | 12 Oct 2005 | 43 |
| 44 | Cyclopropavir Inhibits the Normal Function of the Human Cytomegalovirus UL97 Kinase Scott H. James, Caroll B. Hartline, Emma A. Harden et al. · Antimicrobial Agents and Chemotherapy | 26 Jul 2011 | 43 |
| 45 | Synthesis and Biological Evaluation of Botulinum Neurotoxin A Protease Inhibitors Bing Li, Ramdas P. Pai, Steven C. Cardinale et al. · Journal of Medicinal Chemistry | 15 Feb 2010 | 42 |
| 46 | Identification of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase Donald T. Moir · Current Drug Targets - Infectious Disorders | Sep 2005 | 42 |
| 47 | Synthesis and structure–activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS) John David Williams, Matthew C. Torhan, Venugopal Rao Neelagiri et al. · Bioorganic & Medicinal Chemistry | 14 Jan 2015 | 42 |
| 48 | How do antimalarial drugs reach their intracellular targets? Katherine Basore, Yang Cheng, Ambuj Kumar Kushwaha et al. · Frontiers in Pharmacology | 5 May 2015 | 42 |
| 49 | Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates Michelle M. Butler, John David Williams, Norton P. Peet et al. · Antimicrobial Agents and Chemotherapy | 13 Jul 2010 | 41 |
| 50 | New classes of antibiotics Donald T. Moir, Timothy J. Opperman, Michelle M. Butler et al. · Current Opinion in Pharmacology | 26 Jul 2012 | 40 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.